BLOG

Clinical-trials-arena

Ashvattha previews plans for long Covid trial in mid-2023

Overall, Ashvattha’s strategy will be to prioritise functional outcomes over surrogate markers, Cleland explains. The long Covid field still lacks any standardised clinical trial endpoints, making late-stage trial design a largely uncharted territory.